Special Session 41
3月28日［日］09:45-11:15
|
| |
| |
Global Status and Trend of Prevalence and Medical Care of Heart Failure Worldwide
|
|
|
| |
| |
|
|
| |
Heart failure is progressively and exclusively becoming one of the heaviest burdens for not only socio-economics but also health and welfare worldwide. Since to cleverly conquer the difficulty of the heart failure pandemic is to wisely share the knowledges for heart failure, Japanese Circulation Society needs to stand in solidarity with the countries and people in Asia, US and Europe. Therefore, in this session, we would like to discuss the current status of the prevalence, tendency and treatment of heart failure in different countries to produce the future strategy to control heart failure.
|
|
|
| |
| |
|
|
| |
| |
 |
|
Masafumi Kitakaze
Department of Cardiovascular Medicine, Hanwa Daini Senboku Hospital, Sakai
|
|
 |
|
Carolyn Su Ping Lam
Department of Cardiology, National Heart Centre Singapore, Duke-NUS Medical School, Singapore
|
|
|
| |
| |
| |
| |
|
|
| |
| |
|
|
Carolyn Su Ping Lam
Department of Cardiology, National Heart Centre Singapore, Duke-NUS Medical School, Singapore
|
|
 |
|
Tomomi Ide
Department of Cardiovascular Medicine, Kyushu University, Fukuoka
|
|
|
| |
| |
 |
|
Scott D. Solomon
Cardiovascular Department, Brigham and Women’s Hospital, Harvard Medical School, USA
|
|
 |
|
Mikhail Kosiborod
CV Research, Saint Luke’s Mid America Heart Institute, Kansas, USA
|
|
|
| |
| |
|
|